La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Australian Clinical Labs Bilan de santé
Santé financière contrôle des critères 4/6
Australian Clinical Labs has a total shareholder equity of A$165.0M and total debt of A$78.7M, which brings its debt-to-equity ratio to 47.7%. Its total assets and total liabilities are A$583.7M and A$418.7M respectively. Australian Clinical Labs's EBIT is A$52.7M making its interest coverage ratio 3.4. It has cash and short-term investments of A$25.6M.
Informations clés
47.7%
Ratio d'endettement
AU$78.71m
Dette
Ratio de couverture des intérêts | 3.4x |
Argent liquide | AU$25.60m |
Fonds propres | AU$165.03m |
Total du passif | AU$418.69m |
Total des actifs | AU$583.72m |
Mises à jour récentes de la santé financière
Recent updates
We Think Australian Clinical Labs (ASX:ACL) Is Taking Some Risk With Its Debt
Jun 20Are Investors Undervaluing Australian Clinical Labs Limited (ASX:ACL) By 46%?
Feb 21Is It Time To Consider Buying Australian Clinical Labs Limited (ASX:ACL)?
Dec 08Here's Why We Think Australian Clinical Labs (ASX:ACL) Might Deserve Your Attention Today
Aug 14Australian Clinical Labs Limited (ASX:ACL) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Feb 25New Forecasts: Here's What Analysts Think The Future Holds For Australian Clinical Labs Limited (ASX:ACL)
Dec 22The Market Lifts Australian Clinical Labs Limited (ASX:ACL) Shares 31% But It Can Do More
Dec 21The Strong Earnings Posted By Australian Clinical Labs (ASX:ACL) Are A Good Indication Of The Strength Of The Business
Sep 01Analyse de la situation financière
Passif à court terme: ACL's short term assets (A$125.8M) do not cover its short term liabilities (A$190.0M).
Passif à long terme: ACL's short term assets (A$125.8M) do not cover its long term liabilities (A$228.7M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: ACL's net debt to equity ratio (32.2%) is considered satisfactory.
Réduire la dette: ACL's debt to equity ratio has reduced from 234.7% to 47.7% over the past 5 years.
Couverture de la dette: ACL's debt is well covered by operating cash flow (195.6%).
Couverture des intérêts: ACL's interest payments on its debt are well covered by EBIT (3.4x coverage).